The size of the Compression Garments and Stockings Market in Europe is forecasted to hike to USD 900 million by 2025 from USD 700 million in 2020 and is expected to grow at a CAGR of 5.1% from 2020 to 2025. It captures 25% of the global market.
The increasing workload for varicose veins treatments and orthopedic surgeries is observed ahead with advancements in fabric, and garment designers are likely to propel the region's growth. Outstanding of compression garments is flourishing in exercise settings, and sports are fueling the market. Expanding collaborations and acquisitions as the companies in the market try to combine their status over obtaining small and average producers. Increase in discretionary income of the individuals, growing a large number of hospitals as there is an increase in the number of patients attracted to advertising offers and ease of procurement. Moreover, a flourishing number of chiropractors and physiotherapists advising the usage of compression therapy, particularly for older people, is considered to have notable growth in the region over the review period.
Imperfect patient obedience with compression garments and lack of awareness among the population hinder the growth in the market over the review period. Health issues arise like blood clots; breathing problems due to wearing tight compression and shapewear impede the market demand.
This research report on the European Compression Garments and Stockings Market has been segmented and sub-segmented into the following categories
Regional Analysis:
The European market held for a market share of 25% in the global market in 2019. The compression garments and stockings market in Europe is predicted to be the second-largest region in terms of revenue during the forecast period.
Germany is expected to lead the European market in compression garments and stocking growth over the estimated period. Factors like the growing necessity for compressed garments, the rising aging population being affected by muscular problems are predicted to fuel the growth. Also, increasing injuries concerned with sports has augmented the demand for these garments. The surge in online shopping and growing product advertising are enhancing the market.
The UK is the next leading market followed after Germany because of flourishing awareness regarding physical fitness, growing adoption of compression garments and stockings by athletes and gymnasts. Advance technologies associated with orthopedic surgeries, increasing profitable advertisings, and surging consciousness relevant to the advantages of compression garments like healing effects, reducing swelling quality are projected to boost the market. Increase in expenses in healthcare as these compression garments are to be replaced 2 to 4 times yearly.
Notable companies leading the Europe Compression Garments and Stockings Market Profiled in the Report are Leonisa, Inc., Medical Z, 2XU Pty. Ltd, 3M, BSN Medical, Medi GmbH & Co KG, Nouvelle, Inc., Santemol Group Medical.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Introduction
5.1.2 Compression Garments
5.1.2.1 Upper Compression Garments
5.1.2.2 Lower Compression Garments
5.1.3 Compression Stockings
5.1.3.1 Anti-Embolism Compression Stockings
5.1.3.2 Gradient Compression Stockings
5.1.4 Y-o-Y Growth Analysis, By Product Type
5.1.5 Market Attractiveness Analysis, By Product Type
5.1.6 Market Share Analysis, By Product Type
5.2 Application Type
5.2.1 Introduction
5.2.2 Varicose Vein
5.2.3 Wound Care
5.2.4 Burns
5.2.5 Oncology
5.2.6 Others
5.2.7 Y-o-Y Growth Analysis, By Application Type
5.2.8 Market Attractiveness Analysis, By Application Type
5.2.9 Market Share Analysis, By Application Type
5.3 End-user
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Ambulatory Surgical Centers (ASC’s)
5.3.4 Clinics
5.3.5 Online Sales
5.3.6 Other Healthcare Facilities
5.3.7 Y-o-Y Growth Analysis, By End-user
5.3.8 Market Attractiveness Analysis, By End-user
5.3.9 Market Share Analysis, By End-user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product Type
6.1.3.3 By Application Type
6.1.3.4 By End-user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product Type
6.1.4.3 By Application Type
6.1.4.4 By End-user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product Type
6.1.5.3 By Application Type
6.1.5.4 By End-user
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
6.7 Rest of Europe
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 2XU Pty. Ltd
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 3M
8.3 BSN Medical
8.4 Leonisa, Inc.
8.5 Medical Z
8.6 medi GmbH & Co KG
8.7 Nouvelle, Inc.
8.8 Santemol Group Medical
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
